FRIDAY, Sept. 20, 2024 (HealthDay News) — Heavy-duty endurance exercise can cause body fat levels to drop without any accompanying weight loss, a new small-scale study indicates. A group of eleven middle-aged men who cycled 710 miles in seven days lost only about 1% of their total weight, because theyContinue Reading
WEDNESDAY, Sept. 17, 2024 (HealthDay News) — Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days. They’re in short supply, and often too expensive to afford without insurance coverage. Because of these barriers, many people are doing an end-run around their doctor’s office, reaching outContinue Reading
MONDAY, Sept. 16, 2024 (HealthDay News) — Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that. In a new decades-long study, veterans with diabetes and what’s known as metabolic dysfunction-associated steatotic liverContinue Reading
FRIDAY, Sept. 13, 2024 (HealthDay News) — Ozempic and its weight-loss cousin, Wegovy, outperform another longstanding weight-loss drug that targets the same hormone associated with blood sugar and appetite, a new study finds. Ozempic and Wegovy (semaglutide) promoted the loss of 10% or more body weight in 61% of peopleContinue Reading
FRIDAY, Sept. 13, 2024 (HealthDay News) — Initially approved to treat type 2 diabetes, Ozempic and Mounjaro also can help people with type 1 diabetes lose weight and control their blood sugar levels, a new study finds. Overweight or obese type 1 diabetics taking Mounjaro were able to reduce theContinue Reading
THURSDAY, Sept. 12, 2024 (HealthDay News) — Statistics from 2023 on U.S. obesity rates bring no good news: In every state in the nation, 1 in every 5 people is now obese, the new tally shows. In 2013, not one state had an adult obesity rate topping 35%, but 10Continue Reading
THURSDAY, Sept. 12, 2024 (HealthDay News) — The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the clinical trials that led to its approval. All doses of tirzepatide consistently reduced weight in both women and men, researchers found. ButContinue Reading
THURSDAY, Sept. 12, 2024 (HealthDay News) — Ozempic and Wegovy can prevent heart problems in overweight and obese people, particularly if they also suffer from kidney disease, a new clinical trial shows. The drugs’ active ingredient, semaglutide, reduced heart health risk by 20% in heavyset people who took it forContinue Reading
WEDNESDAY, Sept. 11, 2024 (HealthDay News) — The weight-loss drug liraglutide helped obese children lower their BMI and reach a healthier weight, researchers report. The findings, published Tuesday in the New England Journal of Medicine and presented simultaneously at the European Association for the Study of Diabetes annual meeting in Madrid,Continue Reading
WEDNESDAY, Sept. 11, 2024 (HealthDay News) — An experimental weight-loss pill appears to help people quickly shed pounds, a new study says. People who took the drug amycretin lost up to 13% of their body weight over three months, according to early clinical trial results presented at the European AssociationContinue Reading